MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

Agomelatine

CAS No. : 138112-76-2

MCE 國際站：Agomelatine

產(chǎn)品活性：Agomelatine (S-20098) 是一種 MT1 和 MT2 受體的特異性激動(dòng)劑，對(duì) CHO-hMT1，HEK-hMT1，CHO-hMT2，HEK-hMT2 的 K_i 分別為 0.1，0.06，0.12 和 0.27 nM。Agomelatine 還是一種選擇性的 5-HT2C 受體拮抗劑，在天然 (豬) 和克隆的人 5-HT2C 受體中 pK_i 分別為 6.4 和 6.2。

研究領(lǐng)域：GPCR/G Protein  |  Neuronal Signaling  |  Metabolic Enzyme/Protease

作用靶點(diǎn)：Melatonin Receptor  |  5-HT Receptor  |  Endogenous Metabolite

In Vitro: Agomelatine (S 20098) acts as a full agonist of MT1 and MT2 receptors with EC₅₀s of 1.6±0.4, 0.10±0.04 nM for CHO hMT1, CHO-hMT2 (hΜΤ1 and hΜΤ2 receptors expressed in CHO or HEK cell membranes).
Agomelatine (S20098) also interacts with h5-HT2B receptors (6.6), whereas Agomelatine shows low affinity at native (rat)/cloned, human 5-HT2A (<5.0/5.3) and 5-HT1A (<5.0/5.2) receptors, and negligible (<5.0) affinity for other 5-HT receptors.

In Vivo: Agomelatine (25, 50, or 75 mg/kg; i.p.) has antioxidant activity in Strychnine (75 mg/kg, i.p.) or Pilocarpine (400 mg/kg, i.p.) induced seizure models in mice. Agomelatine dose not have any antioxidant effects on parameters of oxidative stress produced by Pentylenetetrazole (PTZ) or Picrotoxin (PTX) induced seizure models when compared to controls.

相關(guān)產(chǎn)品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Metabolism/Protease Compound Library  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Oxygen Sensing Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Alzheimer's Disease Compound Library  |  Anti-Parkinson's Disease Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Targeted Diversity Library  |  Rare Diseases Drug Library  |  EMA-Approved Drug Library  |  5-HT Receptor Compound Library  |  Human Metabolite Library  |  Coagulation and Anti-coagulation Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Highly Selective Activators Library  |  Rapamycin  |  3-Methyladenine  |  Acetylcysteine  |  5-Fluorouracil  |  ATP  |  Retinoic acid  |  Hydrocortisone  |  Estradiol  |  AICAR  |  Prostaglandin E2  |  Nicotinamide  |  Docetaxel  |  Isoprenaline hydrochloride  |  Cytarabine  |  L-Ascorbic acid  |  Palmitic acid  |  Melatonin  |  Valproic acid  |  Capsaicin  |  Calcitriol  |  Arachidonic acid  |  Acetaminophen  |  β-Nicotinamide mononucleotide  |  Biotin  |  DHEA  |  NAD+  |  Corticosterone  |  Oleic acid  |  Cholesterol  |  Luteolin

熱門產(chǎn)品線：重組蛋白  |  化合物庫  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds